WNT10A heterozygous germline variant was present in the tumor sample with VAF 0.15, which corresponded to the loss of the WNT10A pathogenic variant in the tumor sample (as predicted purity is 0.68 and there is LOH in the WNT10A region (Figure 7D)). Here, WNT10A is linked to neoplasm.